SoCal CTO

JUNE 9, 2010

Kathy Sierra at Business of Software 2009 - Business of Software Blog , May 4, 2010 "In the old days, getting customers was easy. Draw Your Ideas - A VC : Venture Capital and Technology , May 16, 2010 I saw Jack Dorsey give this talk at The 99% Conference last month. You could just outspend. Tesla is not. Stay Tuned.

Startup 248

Startup Venture Capital Conference Social Media 248

Both Sides of the Table

AUGUST 12, 2010

In the VC & Private Equity world there’s a small number, too, with one of the most respected being PEHub. I always wanted to have Dan on This Week in VC with Dan Primack ( to see video click link ) because he’s blunt, honest, opinionated and well informed. Question: Some people are saying traditional VC is dead.

Venture Capital 232

Venture Capital Slides Seed Funding Google 232

Both Sides of the Table

APRIL 13, 2011

Brad on blogging. How did you start blogging? “My My initial desire to blog came from something that’s always been my approach to investing – I’m a nerd and I love to play with the technology and part of my approach has really been to understand things both at a user level and at a reasonably deep tentacle level.

Venture Capital 288

Venture Capital Startup Technical Review Software Review 288

InfoChachkie

DECEMBER 8, 2011

I began our discussion by asking Brad what motivated him to co-author Venture Deals , rather than continuing to share venture capitalists’ secrets via his Ask The VC blog. At one level it’s a terrible return on time investment, but on another level, it’s a really positive one. There were a couple motivations.

Venture Capital 224

Venture Capital Writing Entrepreneur Blogging 224

Both Sides of the Table

JULY 25, 2010

I recently read a book I’d highly recommend to every reader of this blog called “ Yes, 50 Scientifically Proven Ways to be Persuasive &# by Robert B. Rincon is part of the new breed of Seed Stage VCs and with the leadership of Jim Andelman has charted out the most authentic early-stage investment strategy in Southern California.

Guide 293

Guide Funding Venture Capital Technical Review 293

Both Sides of the Table

NOVEMBER 25, 2014

This blog started from a series of conversations I found myself having over and over again with founders and eventually decided I should just start writing them.It He wants to compete to be the lead drummer in the competitive ensemble and study under Terence, an obsessive instructor who is hell bent on winning competitions for the school.

Competition 394

Competition Startup Writing Marketing 394

Xconomy

JANUARY 11, 2017

While we’re looking at venture deal numbers from the past year , let’s consider the education technology industry, which isn’t broken out by sector in the general reports I’ve seen. A recent study by EdSurge , an edtech information firm, shows venture funding for U.S. education tech companies totaled $1.03

Funding 40

Funding Education Venture Capital Study 40

Both Sides of the Table

OCTOBER 5, 2014

I did a study for a large European mobile operator on whether they should bid for 3G spectrum and if so how much was it worth. In my experience many VC’s fall into this “I’m expected to know all the answers” trap. ” I’ve already blogged about how I work through this process: I triangulate.

Entrepreneur 337

Entrepreneur Technical Advisors Startup Venture Capital 337

Xconomy

DECEMBER 20, 2018

New biopharma company Aristea Therapeutics has raised $15 million from Novo Holdings, the Danish investment company, and secured global rights to an investigational AstraZeneca drug that’s ready for Phase 2 study. The San Diego, CA, company made its public debut this week after starting up quietly earlier this year.

Develop 67

Develop Development San Diego Study 67

Xconomy

JULY 27, 2018

Eisai and partner Biogen released the highly anticipated details of an Alzheimer’s disease study they had already deemed positive, after an initial failure. In one sense, the study was the success they have claimed. A high dose of the drug appeared to have a positive impact on patients, compared to placebo.

Study 64

Study Invest San Diego Venture Capital 64

Both Sides of the Table

AUGUST 14, 2009

This is part of my ongoing series Pitching a VC. If you can’t get product released and validated then do user studies. In SoCal we have Crosscut Ventures, Matt Coffin, Mike Jones, Klaus Schauser, etc. They know that the money they invest may be lost. They know all the VCs for intros. They exist in every town.

Angel 291

Angel Funding Venture Capital Startup 291

Xconomy

APRIL 22, 2019

Swiss pharma giant Novartis has invested $75 million in a $142 million Series C round for San Diego-based Poseida, which is one of several companies developing what is meant to be a one-time, long-lasting treatment for multiple myeloma. Multiple myeloma affects about 300,000 Americans every year.

San Diego 83

San Diego Study Funding Invest 83

Xconomy

JANUARY 9, 2019

The Boston company, which counts diabetes drug giants Eli Lilly (NYSE: LLY ) and Novo Nordisk (NYSE: NVO ) among its investors and partners, says the capital will support Phase 3 studies of its device this year, and if all goes well, an application for FDA approval. Beta Bionics’s device is designed to mimic the role of.

Study 87

Study Design Capital Startup 87

Both Sides of the Table

AUGUST 21, 2011

When I first got into VC I decided I better have some investment themes. We now know that the medium has changed the news industry leading to blogs, real-time reporting, integration of text and video, two-way discussions, stories surfaced based on what your friends are reading, etc. “People still want calls …&#.

Mobile 329

Mobile Advertising Media Marketing 329

Xconomy

AUGUST 17, 2016

San Diego’s Avelas Biosciences , founded in 2009 to advance a fluorescing biologic agent intended to help surgeons differentiate cancerous tissue from healthy tissue, has completed a $20 million Series C round of venture funding. and San Diego’s Avalon Ventures. and San Diego’s Avalon Ventures. Carmine Stengone.

Avalon 40

Avalon San Diego Study Invest 40

Both Sides of the Table

SEPTEMBER 21, 2016

Today Upfront Ventures is announcing that we’ve backed Rebecca Kantar ’s startup Imbellus , a company designed to assess human potential and ultimately change the way we teach children. We led a $4 million investment along with Thrive Capital, GLG and Sound Ventures.

Design 150

Design Ideas Startup Writing 150

Xconomy

SEPTEMBER 6, 2019

In presenting clinical data from a Phase 3 study. If MedCo’s cholesterol-lowering drug inclisiran wins FDA approval, it will become the third entry in a new class of medicines that block a cholesterol-boosting protein called PCSK9. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 84

Pricing Class Study Marketing 84

Xconomy

JUNE 13, 2019

The other, for autism, could start a Phase 1 study in 2020. The new Series B round will give San Francisco-based BlackThorn—a startup spun out of the Scripps Research Institute in 2013—the backing to run human tests of two experimental treatments. Those plans. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Tool 78

Tool Study Research Startup 78

Xconomy

DECEMBER 7, 2017

Proceeds will be used to advance Metacrine’s lead drug candidate, MET409, into first-in-human studies during the first half of 2018. Initial studies should be completed by the end of the year, the San Diego-based company said.

San Diego 49

San Diego Study Develop Development 49

Tech Zulu Event

AUGUST 13, 2010

Removing the Middleman: Embedding Shopping on Your Blog. In 2009 my art blog www.johntunger.com earned $188,138 in gross sales from 205,839 unique visitors. Entrepreneurism / Monetization blogging, Entrepreneurship, monetization. . Entrepreneurism / Monetization Funding, psychology , vc. . Unger, John T. Unger, LLC.

Guide 69

Guide Startup Venture Capital Entrepreneur 69

Xconomy

APRIL 6, 2018

The FDA didn’t smile upon a big submission of depression studies from Alkermes, while those fighting liver disease got a mixed slate of data as a big medical conference looms. After the deals, we’ll move on to data. There were plenty of policy and drug-price headlines, Read more » Reprints | Share:

Study 55

Study Pricing Conference Marketing 55

Xconomy

FEBRUARY 15, 2017

Feldstein has been studying the liver for nearly 20 years, and his research now forms the basis of a newly launched company called Jecure Therapeutics. Backed by $20 million in Series A funding from Versant Ventures, San Diego-based Jecure aims to develop a new class of drugs to treat an advanced form of fatty liver disease called.

UCSD 64

UCSD Press San Diego Class 64

Xconomy

MAY 30, 2016

Lita Nelsen has seen it up close—and played a part in its evolution—from her studies there in the 1960s, to her business-school fellowship in the late 1970s, to her 30 years working in MIT’s Technology Licensing Office. MIT’s approach to nurturing entrepreneurship has changed a lot over the past 50 years.

Startup 67

Startup Compton Research Technology 67

Both Sides of the Table

NOVEMBER 4, 2010

The framework of his book has profoundly altered how I think about the technology market and affects how I thought about building my businesses and how I think about investing in venture capital. About how dismissive traditional print was about blogs or the airlines views the “peanut serving&# Southwest Airlines.

Startup 376

Startup Framework Marketing Customer 376

Tech Zulu Event

JULY 18, 2011

Kyle: As I’m sure you’ve seen recently in startup news outlets there’s been discussions about the the bias some VCs may have towards investing in women, what’s your opinion on the discussion about VC/Angels holding back from investing in women founders/CEOs? Andrea: We’re launching a new UI on Tuesday.

Startup 99

Startup Social Media Media Sites 99

Xconomy

SEPTEMBER 21, 2016

At Xconomy, we have seen growing investments in the sector—both in a rash of new agtech startups and by bigger players such Monsanto, Bayer Crop Sciences, and Syngenta. The annual AgTech Investment Report from AgFunderNews found that investment in agriculture and food-related technology startups alone hit $4.6

Newsletter 40

Newsletter Research Technology Equity 40

socalTECH

NOVEMBER 17, 2010

We said to the studios--you have this amazing content, why not let us clip it all up, find the best moments in film, and allow users to post those to their blogs and Facebook pages, and let us create curated channels on the web? Studies show, if you don't, people will turn to piracy. Rich Raddon: There are two things.

Startup 190

Startup Los Angeles Content Hollywood 190

Tech Zulu Event

MAY 10, 2012

His set of studies include examining the conscious control of single neurons in humans, the ability to affect altered states of consciousness as dreams or sleep, and the ability of humans to regulate high-level emotions. Dario studied and/or worked in Hawaii, China, California, Austria and Bosnia. Moran Cerf Ph.D. / @TwtrDtCm.

Technical Advisors 89

Technical Advisors Design Education Study 89

Xconomy

MAY 24, 2019

Patients, doctors, family members, and drug-price watchdogs continued to wait for the expected approval of Zolgensma , a Novartis (NYSE: NVS ) gene therapy for the rare inherited disease spinal muscular atrophy. Originally developed at a children’s hospital in Ohio , Zolgensma will be a litmus test for the nascent field.

Pricing 86

Pricing Marketing Develop Development 86

Xconomy

AUGUST 30, 2019

You might be camping, barbecuing, or sleeping on Monday. It’s Labor Day, after all. But in Paris, this cardiologist will be in a conference center, walking an audience through a slide deck packed with Phase 3 data for a new cholesterol-lowering drug, inclisiran. Inclisiran’s owner, the Medicines Co.,

Slides 80

Slides Conference Venture Capital San Diego 80

Xconomy

APRIL 20, 2018

The biggest news this week was in oncology, hands down. Merck showed that its immunotherapy pembrolizumab (Keytruda) might become a common option for many patients newly diagnosed with advanced lung cancer, but the bigger picture is that the field is moving fast.

Pricing 52

Pricing News Report Develop 52

Startup Professionals Musings

MAY 9, 2011

Rose, who has been described as "the Father of Angel Investing in New York" by Crain's New York Business, and a "world conquering entrepreneur" by BusinessWeek. He chairs New York Angels, one of the most active angel investment groups in the country, which has invested over $60 million into nearly 70 companies.

Invest 88

Invest Angel Venture Capital Entrepreneur 88

Xconomy

AUGUST 12, 2016

Lilly will continue the study, but the news puts distance between abemaciclib and two similar, rival cancer drugs from Pfizer (palbociclib (Ibrance)) and Novartis (ribociclib)). Both Pfizer and Novartis stopped Phase 3 trials of their drugs early because they were clearly benefitting breast cancer patients. In the U.S.,

Google 40

Google Technical Review News Research 40

Xconomy

JUNE 30, 2017

There is no Obamacare replacement, at least not as of this writing. The Senate Republicans are fractured, with a handful of conservatives and moderates each giving a cold shoulder to their chamber’s version of healthcare reform, the Better Care Reconciliation Act.

Writing 56

Writing Report Artificial Inteligence San Diego 56

Xconomy

AUGUST 11, 2017

With President Trump holed up in New Jersey, rattling his saber at Kim Jong-un and Mitch McConnell and ignoring his own commission’s advice on the opioid crisis, there was still life sciences news from the nation’s capital.

Pricing 52

Pricing News Report Competition 52

Both Sides of the Table

DECEMBER 2, 2010

As a VC I’m acutely that a “yes&# decision to support an entrepreneur can do just that, yet I only write 2-4 of them per year and maybe another 3-4 as an angel. You can also spend time with a newer startup helping them navigate the world of product management, venture capital or team building. True story.].

Startup 352

Startup Help Blogging Entrepreneur 352

SoCal CTO

JANUARY 5, 2011

My 1,000th Post on This Blog - Tim Berry's Blog - Planning Startups Stories , July 21, 2010 HTML5 video markup, compatibility and playback - Niall Kennedy's Weblog , February 8, 2010 Your Product Needs a Soul - ArcticStartup , February 12, 2010 Product Friday: Monetizing Content is a Product Problem - This is going to be BIG.

Startup 378

Startup Venture Capital Blogging CTO Coach 378